Risque thrombo-embolique

  • aflibercept (Zaltrap®)
  • axitinib (Inlyta®)
  • bevacizumab (Avastin®)
  • cabozantinib (Cabometyx®)
  • lenvatinib (Lenvima®)
  • pazopanib (Votrient®)
  • sunitinib (Sutent®)
  • vandetanib (Caprelsa®)
  • cetuximab (Erbitux®)
  • abemaciclib (Verzenios®)
  • dabrafenib (Tafinlar®)
  • encorafenib (Braftovi®)
  • binimetinib (Mektovi®)
  • trametinib (Mekinist®)
  • temsirolimus (Torisel®)
  • imatinib (Glivec®)
  • panitumumab (Vectibix®)
  • brigatinib (Alunbrig®)